High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

Published:2012-01 Issue:1 Volume:17 Page:23-27
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Ianni Mauro Di¹,Ballanti Stelvio¹,Iodice Giuseppe²,Reale Antonia²,Falzetti Franca¹,Minelli Olivia³,Serio Gabriella⁴,Martelli Massimo F¹,Dammacco Franco²,Vacca Angelo²,Ria Roberto²

Affiliation:

1. Department of Clinical and Experimental Medicine Section of Hematology and Clinical Immunology, University of Perugia Medical School, I-06100 Perugia, Italy

2. Department of Biomedical Sciences and Human Oncology Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, I-70124 Bari, Italy

3. Immunohematology and Blood Transfusion Service Perugia General Hospital, I-06100 Perugia, Italy

4. Section of Medical StatisticsUniversity of Bari Medical School, I-70124 Bari, Italy

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/102453312X13221316477534

Reference22 articles.

1. Autologous bone marrow transplantation for patients with relapsed hodgkin's disease

2. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

3. High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease

4. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiotepa;Encyclopedia of Toxicology;2024

2. Respiratory Tract Diseases That May Be Mistaken for Infection;Principles and Practice of Transplant Infectious Diseases;2019

3. Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma;Bone Marrow Transplantation;2017-10-16

4. Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?;Expert Opinion on Orphan Drugs;2017-10-08

5. Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review;Bone Marrow Transplantation;2017-01-23